Christopher S. Szyarto

Hematology

1 Genesys Pkwy
Grand Blanc, MI 48439

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial.

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial.

Journal: The Lancet. Oncology

Published: September 16, 2022

Showing 1-1 of 1

Last Updated: 09/26/2026